Winslow Evans & Crocker’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $7K | Hold |
77
| – | – | ﹤0.01% | 1014 |
|
|
2020
Q3 | $6K | Hold |
77
| – | – | ﹤0.01% | 829 |
|
|
2020
Q2 | $9K | Sell |
77
-1
| -1% | -$99 | ﹤0.01% | 752 |
|
|
2020
Q1 | $8K | Hold |
78
| – | – | ﹤0.01% | 734 |
|
|
2019
Q4 | $8K | Hold |
78
| – | – | ﹤0.01% | 851 |
|
|
2019
Q3 | $6K | Hold |
78
| – | – | ﹤0.01% | 899 |
|
|
2019
Q2 | $8K | Sell |
78
-10
| -11% | -$855 | ﹤0.01% | 861 |
|
|
2019
Q1 | $10K | Buy |
88
+10
| +13% | +$927 | ﹤0.01% | 803 |
|
|
2018
Q4 | $8K | Hold |
78
| – | – | ﹤0.01% | 798 |
|
|
2018
Q3 | $8K | Hold |
78
| – | – | ﹤0.01% | 817 |
|
|
2018
Q2 | $8K | Hold |
78
| – | – | ﹤0.01% | 829 |
|
|
2018
Q1 | $6.24K | Hold |
78
| – | – | ﹤0.01% | 879 |
|
|
2017
Q4 | $6.87K | Hold |
78
| – | – | ﹤0.01% | 880 |
|
|
2017
Q3 | $7.17K | Buy |
78
+1
| +1% | +$88 | ﹤0.01% | 873 |
|
|
2017
Q2 | $6.99K | Sell |
77
-1
| -1% | -$91 | ﹤0.01% | 990 |
|
|
2017
Q1 | $6.76K | Hold |
78
| – | – | ﹤0.01% | 976 |
|
|
2016
Q4 | $6.38K | Hold |
78
| – | – | ﹤0.01% | 989 |
|
|
2016
Q3 | $7.13K | Hold |
78
| – | – | ﹤0.01% | 984 |
|
|
2016
Q2 | $5.99K | Buy |
78
+1
| +1% | +$85 | ﹤0.01% | 991 |
|
|
2016
Q1 | $6.35K | Sell |
77
-1
| -1% | -$81 | ﹤0.01% | 973 |
|
|
2015
Q4 | $8.07K | Hold |
78
| – | – | ﹤0.01% | 955 |
|
|
2015
Q3 | $8.11K | Hold |
78
| – | – | ﹤0.01% | 935 |
|
|
2015
Q2 | $10.5K | Hold |
78
| – | – | ﹤0.01% | 918 |
|
|
2015
Q1 | $9.6K | Hold |
78
| – | – | ﹤0.01% | 888 |
|
|
2014
Q4 | $6.96K | Hold |
78
| – | – | ﹤0.01% | 968 |
|
|
2014
Q3 | $5.56K | Sell |
78
-50
| -39% | -$3.29K | ﹤0.01% | 1051 |
|
|
2014
Q2 | $7.96K | Buy |
128
+51
| +66% | +$3.08K | ﹤0.01% | 908 |
|
|
2014
Q1 | $5.25K | Sell |
77
-75
| -49% | -$5.53K | ﹤0.01% | 1008 |
|
|
2013
Q4 | $11K | Buy |
+152
| New | +$10.3K | ﹤0.01% | 864 |
|
Other funds holding BMRN
BBA